新型冠状病毒肺炎心肌酶学改变及其临床意义的研究  

The study on myocardial enzymes of COVID-19 and its clinical significance

作　　者：李玲 郝建清 LI Ling;HAO Jian-qing(DePartment of ResPiratory Medicine,Qingyang PeoPle's HosPital)

机构地区：[1]庆阳市人民医院呼吸内科,甘肃庆阳745000

出　　处：《当代临床医刊》2021年第1期81-82,6,共3页Journal of Contemporary Clinical Medicine

摘　　要：目的分析COVID-19患者心肌酶学改变及其临床意义。方法收集100例COVID-19患者的临床资料及心肌酶学结果,分析死亡组及存活组出现心肌酶升高的比例及差异。结果部分患者出现了心肌酶学异常,CK升高34例(34%),CK-MB升高34例,LDH升高40例,AST升高27例,其中LDH在存活组中有32例升高,死亡组中有8例升高,其升高的比例死亡组高于存活组,差异具有显著的统计学意义。结论新型冠状病毒肺炎患者存在心肌损伤,尽早识别有助于提高治愈率。Objective Analysis ofmyocardial enzymatic changes and its clinical significance in Patients with 2019 novel coronavirus diseases(COVID-19).Methods Collected the clinical data and myocardial enzymatic of COVID-19 Patients,and analysis of the ProPortion and difference of increased myocardial enzyme in death grouP and survival grouP.Results Some Patients showde myocardial enzyme abnormalities,CK increased in 34 Patient(34%),CK-MB increased in 34 Patient(34%),LDH increased in 40 Patient(40%),AST increased in 27 Patient(27%),LDH was elevated in 32 Patients in survival grouP and 8 in death grouP.The elevated ProPortion of deaths was higher than the survival,the difference was statistically significant.Conclusion Myocardial infarction exists in COVID19 Patients,early identification can imProve the cure rate.

关 键 词：新型冠状病毒 新型冠状病毒肺炎 心肌酶 乳酸脱氢酶 

分 类 号：R563.1[医药卫生—呼吸系统]